Skip to main content

Table 2 Patient characteristics for serum microRNA analysis

From: Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT

ParameterClinical remission patientsRecurrence or distant metastasis patients  
N%N%χ2P
Gendermale1578.9%2482.8%0.000*1
female421.1%517.2%  
Age (years)≤601052.6%1448.3%0.0870.768
> 60947.4%1551.7%  
T stageT1-T21263.2%1241.4%2.1780.14
T3-T4736.8%1758.6%  
N stageN0-N11263.2%1862.1%0.0060.939
N2-N3736.8%1137.9%  
Tumor stageII-III947.4%827.6%1.9640.161
IV1052.6%2172.4%  
Pathological typedifferentiated1157.9%1448.3%1.4780.153
undifferentiated842.1%1551.7%  
Ki-67+1368.4%1344.8%2.5470.144
++631.6%1655.2%